Award notice, 8(a) sole source

Relenza, NDC# 00173-0681-22

Relenza

Office of the Assistant Secretary for Administration (Asa), Program Support Center Acq MGMT SVC. Biological Product (except Diagnostic) Manufacturing.

View on SAM.gov Markdown

Awarded

GLAXOSMITHKLINE, LLC Durham

$249,900.00 on the award notice, July 23, 2024, contract Relenza

Description

As published on SAM.gov.

'Relenza', Zanamivir inhalant powder, 5mg, 20s, NDC# 00173-0681-22, quantity 9,520 packages.

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

July 16, 2024
Award notice
Awarded to GLAXOSMITHKLINE, LLC Durham for $249,900. SAM.gov, notice df692f0cf01e48cb939598b378541e24

Points of contact

Tim BouchelleTimothy.Bouchelle@hhs.gov4439476039

ScriptPro Upgrade and Maintenance
Combined synopsis and solicitationNAICS 54151926-SOL-IHS1524457
Closes in 3 daysSep 21

Relenza, NDC# 00173-0681-22

Description

Publications

Points of contact

Also open from this buyer